Patents by Inventor Ramesh Vemulapalli

Ramesh Vemulapalli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080069824
    Abstract: An isolated and purified antigen which is expressed by a wild-type E. risticii strain and is specific to the stain. The present invention also relates to nucleic acid constructs which encode the antigen, expression vectors, transformed host cells, and methods for producing the antigen.
    Type: Application
    Filed: November 3, 2005
    Publication date: March 20, 2008
    Inventors: Sukanta Dutta, Biswajit Biswas, Ramesh Vemulapalli
  • Patent number: 6811787
    Abstract: This invention relates to an over-expressing homologous antigen vaccine, a method of producing the same, and use of the vaccine for prophylaxis or treatment of vertebrates at risk of or suffering from disease caused by a pathogenic micro-organism. The vaccine is an attenuated or avirulent pathogenic micro-organism that over-expresses at least one homologous antigen encoded by at least one gene derived from the pathogenic micro-organism, and may also express a heterologous antigen.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: November 2, 2004
    Assignees: The Regents of the University of California, Virginia Tech Intellectual Properties, Inc.
    Inventors: Stephen M. Boyle, Silvio Cravero, Lynette Corbeil, Gerhardt Schurig, Nammalwar Srirnaganathan, Ramesh Vemulapalli
  • Publication number: 20040191262
    Abstract: An isolated and purified antigen which is expressed by a wild-type E. risticii strain and is specific to the strain. The present invention also relates to nucleic acid constructs which encode the antigen, expression vectors, transformed host cells, and methods for producing the antigen.
    Type: Application
    Filed: January 23, 2002
    Publication date: September 30, 2004
    Inventors: Sukanta Dutta, Biswajit Biswas, Ramesh Vemulapalli
  • Patent number: 6375954
    Abstract: An isolated and purified antigen which is expressed by a wild-type E. risticii strain and is specific to the strain. The present invention also relates to nucleic acid constructs which encode the antigen, expression vectors, transformed host cells, and methods for producing the antigen.
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: April 23, 2002
    Assignee: University of Maryland College Park
    Inventors: Sukanta Dutta, Biswajit Biswas, Ramesh Vemulapalli
  • Patent number: 6149920
    Abstract: This invention relates to an over-expressing homologous antigen vaccine, a method of producing the same, and use of the vaccine for prophylaxis or treatment of vertebrates at risk of or suffering from disease caused by a pathogenic micro-organism. The vaccine is an attenuated or avirulent pathogenic micro-organism that over-expresses at least one homologous antigen encoded by at least one gene derived from the pathogenic micro-organism, and may also express a heterologous antigen.
    Type: Grant
    Filed: June 19, 1998
    Date of Patent: November 21, 2000
    Assignees: The Regents of the University of California, Virginia Tech Intellectual Properties, Inc.
    Inventors: Stephen M. Boyle, Silvio Cravero, Lynette Corbeil, Gerhardt Schurig, Nammalwar Srirnaganathan, Ramesh Vemulapalli